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Background. Diabetes patients are at high risk for 
cardiovascular disease. Evidence and guidelines 
recommending the use of multiple cardiovascular 
medications to support the management of diabetes 
have been well-established. It is nevertheless of 
growing concern that the bene#ts conferred by 
combination of the drugs are potentially o"set by 
perceived deterioration on health-related quality of life 
(HRQoL) attributable to pill burden. 
Objectives. A cross-sectional study was conducted 
to determine the extent of use of cardiovascular 
medications in elderly Australian women with 
diabetes–either individually or in combination–for 
primary and secondary prevention of cardiovascular 
disease. This study further examined whether usage 
patterns of cardiovascular medications have e"ects on 
their health-related quality of life.
Methods. A subset of the older cohort completing 
Survey 4 in the ALSWH who self-reported to have 
been diagnosed with diabetes and/or use medications 
indicative of diabetes were selected as study subjects. 
Use of cardiovascular medications was identi#ed from 
self-reports on usage of medications belonging to the 
Anatomical Theraupetic Chemical (ATC) code B01AC 
(platelet aggregation inhibitors), C03 (diuretics), C07 
(β-blockers), C08 (calcium channel blockers), C09 
(agents acting on the renin-angiotensin system), C02 
(other antihypertensives) and C10 (lipid modifying 
agents). Prevention stage of cardiovascular disease 
was determined by presence of macrovascular disease 
identi#ed from self-reports of having at least one of 
the following conditions: stroke, heart disease (angina, 
heart attack, other heart problems), had undergone 
or on waiting list for a heart surgery (heart bypass, 
angioplasty, angiography), or on any of cardiac drugs 
(ATC code C01) or warfarin (ATC code B01AA). Patterns 
of cardiovascular drug use were classi#ed as no use, 
using any antihypertensives, lipid lowering agents or 
antiplatelet drugs, using any two combinations, and 
using all the three classes of medications. Quality of life 
was measured with the use of the SF-36, focusing on 
the physical functioning, general health, vitality and 
mental health subscales. Linear regression analyses 
of survey data evaluated the associations between 
usage patterns of cardiovascular medication and 
individual subscales of the SF-36 while controlling for 
other sociodemographic, health behaviour and health 
service utilisation characteristics. 
Results. Of 7,158 older women retained at Survey 4, 
885 were identi#ed as having diabetes among which 
390 (46.8%) had macrovascular disease. Twenty-
three percent of the diabetic women used any one 
category of antihypertensives, lipid lowering drugs 
or antiplatelets, 37.5% reported use of a combination 
of any two and 29.1% were on all three categories 
of medicines. Using at least one cardiovacular drug 
was shown to be associated with higher HRQoL 
scores. After adjustment for other covariates, being 
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Figure 1. Cardiovascular medication use by presence of macrovascular 
disease. Panel A shows usage prevalences of antiplatelet, lipid 
lowering drug and antihypertensive classes. Panel B shows the overall 
pattern of cardiovascular drug use. Signi#cant estimate di$erences 
between the two groups (with & without MVD) are indicated by 
non-overlapped 95% CIs. Abbreviations: LLA, lipid lowering agent; 
CCB, calcium channel blocker; ACEI, angiotensin converting enzyme 
inhibitor; ARB, angiotensin II receptor blocker; AH, antihypertensive; 
MVD, macrovascular disease; CI, con#dence interval.
Figure 2. Radar chart of the quality of life models. Di$erent markers 
connected with their corresponding lines represent regression 
coe"cients of each QoL subscales. A coe"cient of 0 means no 
associations between variables and QoL scores are found. Usages 
of cardiovascular medication are mostly shown to be subjectively 
bene#cial as markers reside in outer area, while other covariates 
are shown to have negative e$ects on QoL indicated by markers 
sitting within grey area. Abbreviations: QoL, quality of life; CAM, 
complementary and alternative medicines; GP, general practitioner
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on triple combination of cardiovascular drugs was 
signi#cantly associated with increased scores on 
physical functioning (coe=cient 16.134, 95% CI 
6.940, 25.327), general health (10.058, 95% CI 2.649, 
17.468) and mental health subscales (12.896, 95% 
CI 6.562, 15.882). Being on any dual combination 
was signi#cantly associated with increased scores 
on physical functioning (coe=cient 14.744, 95% 
CI 5.988, 23.501) and general health (8.334, 95% CI 
1.200, 15.467), whereas using a single cardiovascular 
drug is only signi#cantly associated with increased 
score on physical functioning (coe=cient 12.346, 95% 
CI 3.943, 20.750). A negative association was found 
between using three cardiovascular drugs and vitality 
score albeit modest and statistically nonsigni#cant 
(coe=cient -1.342, 95% CI -7.927, 5.242).
Conclusion. The use of cardiovascular medications 
in elderly Australian women with diabetes was 
reasonably high particularly for the secondary 
prevention of cardiovascular disease. Use of multiple 
cardiovascular drugs was demonstrated to be 
subjectively bene#cial in terms of perceived physical 
functioning, general health and mental health. There 
remains a possibility that being on more intensive 
regimens with more cardiovascular drugs will diminish 
patients’ HRQoL since the remaining subscales of the 
SF-36 were not evaluated. If HRQoL in diabetics is to be 
more comprehensively assessed, there may be value in 
employing a diabetes-speci#c instrument as an add-on 
to the generic HRQoL instrument. 
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Several studies have examined the role of speci#c 
types of trauma (E.g., sexual and physical trauma) on 
the behaviours of women, including their use of health 
behaviours such as smoking, alcohol and illicit drug 
use (Rheinhold et al., 2004, Chang, Skinner & Boehmer., 
2001, Lang et al., 2003, Hapke et al., 2005 and Win#eld 
et al., 1990). This study expanded these #ndings to 
examine the relationship between both major trauma 
and ongoing life events and the use of tobacco, risky 
drinking, illicit drug use, unhealthy eating behaviours, 
self harm and suicidal ideation in young women. The 
longitudinal mailed survey of 7675 women utilised 
generalised estimating equations to examine these 
relationships, #nding that following a major traumatic 
event/s women were signi#cantly more likely to start 
using the above negative health behaviours. Women 
who had higher numbers of ongoing life events were 
also signi#cantly more likely to start using negative 
health behaviours. This study, using the ALSWH data 
has been able to expand substantially on providing 
further knowledge about the ways in which women 
develop various types of health behaviours following 
traumatic and ongoing life events over time. 
